Market Overview:
The global stem cell characterization kits market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for stem cell-based therapies and rising investments in regenerative medicine. Based on type, the embryonic stem cells segment is expected to account for the largest share of the global market in 2018. This segment is also projected to grow at a higher CAGR than other segments during the forecast period. The high growth rate of this segment can be attributed to increasing research and development activities focused on embryonic stem cells. Based on application, biopharmaceutical companies are expected to account for the largest share of the global market in 2018.
Product Definition:
A stem cell characterization kit is a set of tools used to identify and characterize the properties of stem cells. This type of kit can be used to isolate stem cells from different tissue sources, examine their morphology, and determine their ability to differentiate into other cell types. The importance of stem cell characterization kits lies in their ability to help researchers study the potential therapeutic applications of stem cells and improve our understanding of how they work.
Embryonic Stem Cells:
Embryonic stem cells (ESCs) are the pluripotent cells that can differentiate into all germ layers during development. These are mainly derived from the blastocyst stage of an embryo, which is generally around Day 5-6 of a normal menstrual cycle. They possess great plasticity and self-renewal properties, allowing them to be used for research purposes in vitro as well as in vivo.
Mesenchymal Stem Cells:
Mesenchymal stem cells (MSCs) are a type of adult stem cell that can differentiate into a variety of lineages including cartilage, bone marrow, fat, and muscle. MSCs have been found to be involved in the repair and regeneration of damaged tissues as well as exhibit immunomodulatory properties.
Application Insights:
The biopharmaceutical companies segment dominated the global market in 2017. This can be attributed to factors such as high demand for drugs and increasing government support for stem cell research. For instance, in October 2016, the Indian Government approved ¢â‚¬Å“ regenerative medicine¢â‚¬ as a priority therapy under the Indian Stem Cell Regulation Act 2012. The act states that any application seeking approval of a new drug must demonstrate that it does not conflict with any existing regulations regarding human embryo research or reproductive technology and is safe for use outside uterus.
In addition, contract research organizations (CROs) are also anticipated to exhibit lucrative growth over the forecast period owing to their ability to perform multiplexed experiments at lower costs than biopharmaceutical companies due largely without doubt derived from economies of scale inherent in such activities coupled with expertise developed through years of experience working on very large scale projects which include both therapeutic.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2016. The growth can be attributed to the presence of a large number of biopharmaceutical companies and academic & research institutes involved in stem cell research. Moreover, these companies are engaged in collaborations with entities operating outside North America for access to novel drug molecules developed from adult stem cells and other advanced therapies.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing government funding for basic as well as clinical studies related to stem cells along with rising awareness about regenerative medicine approaches among patients & consumers. In addition, an increase in outsourcing activities by leading biopharmaceutical firms based within this region is anticipated to fuel market development during the forecast period – major factors responsible for regional market expansion.
Growth Factors:
- Increasing demand for stem cell therapies for various diseases is expected to drive the growth of the stem cell characterization kits market.
- Rising number of research and development activities in the field of regenerative medicine is also anticipated to fuel the demand for stem cell characterization kits over the forecast period.
- Growing investments by private and public sector organizations for stem cell research is another key factor that would propel market growth during the forecast period.
- Technological advancements in molecular biology techniques are expected to create new opportunities for players operating in this market during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Stem Cell Characterization Kits Market Research Report
By Type
Embryonic Stem Cells, Mesenchymal Stem Cells, Induced Pluripotent Stem Cells
By Application
Biopharmaceutical Companies, Contract Research Organizations, Academics and Research Institutes, Biotechnology Companies
By Companies
Merck KGaA, Celprogen, Creative Bioarray, Thermo Fisher Scientific, BD Biosciences, Research and Diagnostic Systems, System Biosciences, Cosmo Bio USA, BioCat GmbH, Sumitomo Dainippon Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Stem Cell Characterization Kits Market Report Segments:
The global Stem Cell Characterization Kits market is segmented on the basis of:
Types
Embryonic Stem Cells, Mesenchymal Stem Cells, Induced Pluripotent Stem Cells
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceutical Companies, Contract Research Organizations, Academics and Research Institutes, Biotechnology Companies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck KGaA
- Celprogen
- Creative Bioarray
- Thermo Fisher Scientific
- BD Biosciences
- Research and Diagnostic Systems
- System Biosciences
- Cosmo Bio USA
- BioCat GmbH
- Sumitomo Dainippon Pharma
Highlights of The Stem Cell Characterization Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Embryonic Stem Cells
- Mesenchymal Stem Cells
- Induced Pluripotent Stem Cells
- By Application:
- Biopharmaceutical Companies
- Contract Research Organizations
- Academics and Research Institutes
- Biotechnology Companies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Stem Cell Characterization Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Stem Cell Characterization Kits are used to characterize stem cells.
Some of the major companies in the stem cell characterization kits market are Merck KGaA, Celprogen, Creative Bioarray, Thermo Fisher Scientific, BD Biosciences, Research and Diagnostic Systems, System Biosciences, Cosmo Bio USA, BioCat GmbH, Sumitomo Dainippon Pharma.
The stem cell characterization kits market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Stem Cell Characterization Kits Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Stem Cell Characterization Kits Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Stem Cell Characterization Kits Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Stem Cell Characterization Kits Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Stem Cell Characterization Kits Market Size & Forecast, 2020-2028
4.5.1 Stem Cell Characterization Kits Market Size and Y-o-Y Growth
4.5.2 Stem Cell Characterization Kits Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Embryonic Stem Cells
5.2.2 Mesenchymal Stem Cells
5.2.3 Induced Pluripotent Stem Cells
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Biopharmaceutical Companies
6.2.2 Contract Research Organizations
6.2.3 Academics and Research Institutes
6.2.4 Biotechnology Companies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Stem Cell Characterization Kits Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Stem Cell Characterization Kits Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Embryonic Stem Cells
9.6.2 Mesenchymal Stem Cells
9.6.3 Induced Pluripotent Stem Cells
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Biopharmaceutical Companies
9.10.2 Contract Research Organizations
9.10.3 Academics and Research Institutes
9.10.4 Biotechnology Companies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Embryonic Stem Cells
10.6.2 Mesenchymal Stem Cells
10.6.3 Induced Pluripotent Stem Cells
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Biopharmaceutical Companies
10.10.2 Contract Research Organizations
10.10.3 Academics and Research Institutes
10.10.4 Biotechnology Companies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Embryonic Stem Cells
11.6.2 Mesenchymal Stem Cells
11.6.3 Induced Pluripotent Stem Cells
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Biopharmaceutical Companies
11.10.2 Contract Research Organizations
11.10.3 Academics and Research Institutes
11.10.4 Biotechnology Companies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Embryonic Stem Cells
12.6.2 Mesenchymal Stem Cells
12.6.3 Induced Pluripotent Stem Cells
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Biopharmaceutical Companies
12.10.2 Contract Research Organizations
12.10.3 Academics and Research Institutes
12.10.4 Biotechnology Companies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Embryonic Stem Cells
13.6.2 Mesenchymal Stem Cells
13.6.3 Induced Pluripotent Stem Cells
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Biopharmaceutical Companies
13.10.2 Contract Research Organizations
13.10.3 Academics and Research Institutes
13.10.4 Biotechnology Companies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Stem Cell Characterization Kits Market: Competitive Dashboard
14.2 Global Stem Cell Characterization Kits Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck KGaA
14.3.2 Celprogen
14.3.3 Creative Bioarray
14.3.4 Thermo Fisher Scientific
14.3.5 BD Biosciences
14.3.6 Research and Diagnostic Systems
14.3.7 System Biosciences
14.3.8 Cosmo Bio USA
14.3.9 BioCat GmbH
14.3.10 Sumitomo Dainippon Pharma
